Congenital pontocerebellar atrophy and telencephalic defects in
Transcription
Congenital pontocerebellar atrophy and telencephalic defects in
Acta Neuropathol (2007) 114:387–399 DOI 10.1007/s00401-007-0248-z ORIGINAL PAPER Congenital pontocerebellar atrophy and telencephalic defects in three siblings: a new subtype Jules G. Leroy · Gilles Lyon · Catherine Fallet · Jeanne Amiel · Claudine De Praeter · Caroline Van Den Broecke · Piet Vanhaesebrouck Received: 28 October 2006 / Revised: 30 May 2007 / Accepted: 4 June 2007 / Published online: 13 July 2007 © Springer-Verlag 2007 Abstract We report three siblings, two of whom had a neuropathological study, with a new subtype of congenital ponto-cerebellar atrophy (PCH). In addition to the brain stem and cerebellar anomalies common to all types of this heterogeneous condition, there were unique developmental defects in the telencephalon: absence of the claustrum, diVuse cortical changes particularly in the insula and an extremely small brain. In an attempt to shed some light on the pathogenesis of this developmental disorder, we have analyzed the pattern of brain stem and cerebellar abnormalities in ours and in previously reported patients with PCH, to possibly distinguish primary from secondary eVects of the mutant gene upon the cerebellar circuitry, and compared our patients’ cerebellar and cerebral defects to those of some other human brain malformations and to mutant mice with both hindbrain and forebrain anomalies. Although this and previous observations of familial J. G. Leroy (&) · C. De Praeter · C. Van Den Broecke · P. Vanhaesebrouck Departments of Pediatrics, Neonatology and Pathology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium e-mail: [email protected] G. Lyon Department of Child Neurology, Hôpital R. Debré, University of Paris, Paris, France G. Lyon · J. Amiel Department of Clinical Genetics, Hôpital Necker–Enfants Malades, University of Paris, Paris, France C. Fallet Department of Neuropathology, Hôpital Ste. Anne, University of Paris, Paris, France congenital PCH with apparent autosomal recessive inheritance spawn the endeavor to compare and classify patients into subgroups, any Wnal classiWcation must await identiWcation and molecular characterization of the causal gene(s). Keywords Congenital olivo-ponto-cerebellar atrophy (COPCA) · Pontocerebellar hypoplasia (PCH) · Telencephalic dysplasia · Familial micrencephaly · Neocerebellar developmental defect · Autosomal recessive inheritance Introduction Congenital pontocerebellar hypoplasia (PCH), also termed congenital olivopontocerebellar atrophy (COPCA) is the name given to a group of rare, autosomal recessive developmental disorders of unknown pathogenesis with severe expression in the neonate and young infant. This syndrome is characterized by a speciWc constellation of morphologic anomalies: atrophy of the pontine basis with a major reduction of pontocerebellar neurons, small middle cerebellar peduncles, atrophy (i.e. reduction in size with neuronal degeneration) or hypoplasia (i.e. small size without tissue necrosis) of the neo-cerebellum with relative preservation of the vermis and Xocculonodular lobes and various changes in the dentate nucleus and inferior olives. In patients reported up to now, the cerebrum is smaller than normal without speciWc or consistent histologic anomalies. In many reports, the reason for using either “atrophy” or “hypoplasia” is not explained. Although these terms express evident morphologic diVerences–essentially in the neocerebellum–it seems highly probable that both processes, which may coexist in the same patient, are the result of the same genetic defect. According to clinical and 123 388 neuropathological criteria, Barth [3–5] has isolated two main categories of this condition: PCH type 1 with concomitant evidence of spinal muscular atrophy and PCH type 2 in which dystonia is a major feature (Tables 1, 2). Other patients with acute neurological signs and a rapidly fatal course have been reported under various denominations, which we provisionally group under the heading “severe neonatal form” (Table 3). The three siblings here reported, two of them with a neuropathology study, had some clinical features of the latter group, but diVer markedly from the patients in all previous reports on non-syndromic PCH with complete neuropathological description, because of their unique telencephalic abnormalities. Clinical reports Patient 1. This male infant was born at 38-week gestation to healthy nonconsanguineous parents. Prior to this pregnancy, there was a Wrst trimester abortion and the second pregnancy resulted in a healthy boy. The third pregnancy was complicated at 33 weeks by polyhydramnios and a decelerating growth rate of the biparietal diameter (BPD). Birth weight was 2,850 g, length 50 cm, occipitofrontal circumference (OFC) 30 cm. The newborn required immediate ventilatory support. He had no suction reXex and showed generalized hypertonia and intermittent tonic seizures. Ophthalmologic examination, routine laboratory investigations and metabolic studies were normal. A CT scan showed severe reduction of the cerebral volume and much widened subarachnoidal spaces. The karyotype was 46 XY. The tonic convulsions gradually led to status epilepticus, signiWcant O2-desaturation and fatal outcome within the Wrst day of life. Only gross post-mortem examination was performed. The brain weighed 70 g. Patient 2. At 29 weeks, the next pregnancy was also complicated by polyhydramnios and decelerating growth rate of the BPD. Fetal movements, abdominal circumference and femoral length remained normal. Induction of labor at 40 weeks resulted in the delivery of a female infant with birth weight 4,000 g, length 52 cm and OFC 32 cm. Apgar scores were 5 and 8 at 1 and 5 min respectively, but soon respiratory support was required. The suction reXex could not be elicited. All routine laboratory tests yielded normal results. The karyotype was 46, XX. Ultrasonographic abnormalities and CT Wndings in the brain were identical to those of patient 1. The small size of the brain was again disproportionate to the near normal head circumference. Over the next few days, the infant showed increasing generalized hypertonia and seizures. On day 5 status epilepticus led to intractable desaturation and fatal out- 123 Acta Neuropathol (2007) 114:387–399 come. A complete post-mortem examination of the central nervous system was performed. Patient 3. During the Wfth pregnancy a deceleration of the PBD growth was noticed at 30 weeks, although fetal movements, abdominal circumference and femoral length remained normal. A female infant was born at 37 weeks with birth weight 3,225 g, length 48 cm and OFC 31 cm. The Apgar scores were 6 and 9 at 1 and 5 min. The suction reXex absent initially, remained deWcient. DiYculty of oral feeding was compounded by tonic seizures associated with spells of apnea, bradycardia and O2-desaturation. An exaggerated startle response (hyperacousis) was noticed. All laboratory examinations were normal. MRI imaging (Fig. 1) of the brain showed gross abnormalities congruent with those in the previously deceased sibs. The patient succumbed on day 22 during an episode of convulsions. A complete post-mortem examination of the CNS was performed. Materials and methods Brains were Wxed in 10% formaldehyde for 20 days. They were then cut in the coronal plane. Sections of whole hemispheres and brain stem with cerebellum were embedded in paraYn. ParaYn blocks were cut in 7 m sections. The latter were stained with hemalunphloxin, cresyl violet and luxol fast blue. Sections were also stained immunohistochemically with primary monoclonal antibodies: Vimentin (1:100 Dako, USA), NeuroWlament Protein (1:100 Dako, clone 2F11), Calbindin (1:10 000, Swart, Switzerland), Map-2 (1:100, Sigma, clone HM32) or Reelin (GoVinet AL, Department of pharmaceutical chemistry, University of Louvain Medical school, Brussels, Belgium) [19] and with a polyclonal antibody to Pax6 (Rabbit 1/150e, Dako, Covance, USA). They were also immunostained with a polyclonal antibody to GFAP (1:200–1:400, Dako, USA). The universal immunostaining system streptavidin-peroxydase kit Immunotech (Coulter) was used to develop these reactions. Slide-mounted sections were incubated for 30 min in citrate buVer at 98°C in a microwave oven and rinsed in distilled water. After washing in PBS the slides were treated with Protein Blocking Agent (PBA) for 5 min (100 l/slide) at room temperature without rinsing. Subsequently, they were incubated for 60 min at room temperature with the primary antibody Vimentin, GFAP, MAP2 or Reelin, rinsed twice in PBS and incubated with the biotinylated secondary antibody for 30 min at room temperature. In order to complete the reactions, slides were rinsed twice (each time 5 min) in PBS, incubated in Streptavidin–Peroxydase Complex for 45 min, rinsed twice in PBS and covered for 5 min with a freshly prepared DAB solution (100 l/slide). Hematoxylin was used as the counterstain. M Sex neuronal loss ++ + [a,b] + + + [a,d] + + [a,c] ++ ++ + + nl + ++ + + + + 40 F 2 [5] + + F 1 (36) [6] + + + + 32 F 1 (42)(x) + + [a,d] + + [f] ++ + + 450 + nl + + + 300 + [a,c] ++ ++ + + 520 [b] § + +: present; –: absent; blank: not mentioned, irrelevant, absent?; nl: normal; * 2 sibs also aVected; (x) sibs SMA: spinal muscular atrophy; aut: autolysis [1] pyramidal signs, hypertonia; [2] pyramidal signs, vocal cord paralysis, blindness; [3] blindness? vocal cord paralysis; cousin with SMA; [4] clubfeet; hip dislocation; cardiomyopathy; [5] horizontal nystagmus; [6] pyramidal signs; no swallowing; cleft palate; hypoplastic ovaries; [7] seizures [a] normal cortex and basal ganglia; [b] thin corpus callosum; [c] atrophy, gliosis of white matter; [d] gliosis in thalamus; [e] brain atrophy; [f] neuronal loss in striatum (spinal cord § brainstem and thalamus) SMA: neuronal degeneration Cerebrum neuronal loss Inferior olives: poorly convoluted – + + Dentate nucleus: “typical” clusters § + 475 [4] + + 40 M 1 (16) [7] + + + + + 38 F 2 + + + 33 [3 months] + 40 F 1 (28)(x) + [e] + ++ – [a] ++ ++ 2 months 6 months 1 month 2 years 1 months 1 month 3 months Ventral pons atrophy/hypoplasia + 350 + [3] ++ + Neocerebellar atrophy/hypoplasia 880 4 days 3 months [2][3] + “DiVuse” cerebellar atrophy/hypoplasia 603 6 months 22 months Brain weight (g) Neuropathology Age at death [1] + + + Other + + Developmental retardation – + + + 38 F 1 (21) 36 [6 weeks] nl 40 F 1 (29)* Arthrogryposis SMA Neurological signs/symptoms + + Facial dysmorphic features Hypoventilation/apnea (respir. failure) 41 M 1 (63) 46 [22 months] 33.5 40 M 1 (45) OFC (cm) at birth or at [age] Polyhydramnios Term of pregnancy (weeks) + 1 Patient number Clinical data (44) Reference number Table 1 Patients reported with congenital Olivo-Ponto-Cerebellar atrophy Barth type I [7] + + + 40 F 3 + aut aut aut + [f] + – ++ + 17 weeks 1 month + + F 2 Acta Neuropathol (2007) 114:387–399 389 123 123 1 F Patients number Sex [11 months] [15 months] + at [age] Microcephaly 15 months – + + + + 735 2.5 years + + + [24 months] 42 40 M 1 – – [c,e] [f] + + + + + s + + + 1 (54) (9) [h,i] § + + + 1,000 37 40 M 2 + + + + – + 6 months + + + + [18 months] [6 months] 49.5 40 M 1 (49)(x) 3.5 years 18 months + + + + 40 F 1 (31) 31 40 F 1 + + + + + + + + + [3 months] [bi] 36 40 F 1 (52) + + + + + F 1 (3,5,27) + + + F 2 + + + F 1 (56) + + + M 1 (59) + + + M 1 (30) [c,h] + + + + + + 760 – [c] – § + + + 535 [g,h] + + + 395 – [a,h] + + + + + [j] § + + – + + + 1,050 [a,c] – ++ + + 558 – + + 12 months 30 months 16 months 1.2 years 9.2 years 3 years 30 months 18 months + + + + 40 M 3 (27) +: present; –: absent; blank: not mentioned, irrelevant, absent?; bi: birth; s: small; *: dysmorphic features not reported; arthrogryposis: not reported; polyhydramnios not observed; respiratory failure not reported [a] thin corpus callosum; [b] microgyric segment; heterotopias; [c] no signiWcant histologic changes; [d] large putamen; [e] no arcuate nucleus; [f] cleft putamen/insula; [g] thalamus: neuronal loss; gliosis; [h] atrophy; gliosis white matter; [i] no pyramidal tract; [j] poor cortical lamination – [c,d,e] [a,b] – + SMA lesions – + + Neuronal loss + + Cerebrum atrophy/ hypoplasia Abno. convolutions; fragmented Inferior olives Neuronal loss “Typical clusters” + + Ventral pons atrophy/hypoplasia Dentate nucleus + Neocerebellar atrophy/hypoplasia + 610 + Brain weight (g) Neuropathology + Developmental retardation + Age at death 11 months Pyramidal signs + + + + Hypertonia + + Dystonia Seizures + 40 Neurological signs/symptoms 40 38 OFC (cm) F 1 (12,13) Term of pregnancy (weeks) <40 Clinical data* (11) Reference number Table 2 Patients reported with congenital Olivo-Ponto-Cerebellar atrophy, Barth type II 390 Acta Neuropathol (2007) 114:387–399 M Sex + + Arthrogryposis Early respiratory failure + + + + + 27 + 36 M 2 297 + + + 27 35 M 2 1 + + + + 27 34 M F 3 + + + + 37 F 2 + + + 25 + 30 F 1 – [b] + + + + + [c] + – + + – [b] + – + – + – [b] + – + – + + 104 – [c] ++ + ++ ++ + + 160 [c,d,f] ++ + ++ + + 375 [e] ++ + + + + + 145 [e] ++ + + + + + 135 ++ + + + + + 63 [c,d] ++ ++ ++ ++ 198 + 135 – [c,h] + + ++ – [c,h] + + ++ + + 140 + + + + 25 + 30 F 2 + + + + 33 F 1 (20) – [b,c] + ++ + 175 [j] + + + [i] – 175 + + +[3] + – 32 38 F 1 48(x) F 3 M 1 +[3] – +[3] – 18[2] [j] + + + [i] – [j] + + + [i] – 105* 32.5** – + + + – 32 + 40 F 2 – + + + – 31 – 37 F 3 + + 70 – [g] + + + + + + 74 – [g] + + + + + + 78 1 day 5 days 22 days – + + – 30 + 27[1] 20[1] (1) 38 F 2 This report(x) +: present; –: absent; blank: no data or item irrelevant; pm: post-mortem; (x): sibs; (x)(x) identical twins; * Pregnancy interrupted at 27 weeks, ** at 20 weeks gestation: see corresponding norms in (48) [a] ischemic changes; [b] no signiWcant microscopic abnormalities;[c] gliosis in white matter § basal ganglia; [d] thin corpus callosum; [e] mild microgyria, no separation caudate nucleus; [f] heterotopias; [g] no claustrum, cortical dysgenesis; [h] simpliWed gyri; [i] vermis most aVected; [j] irregular layer 2 [1] termination of pregnancy; [2] Normal: 16.7 cm (Ref. [48]); [3] fetal onset of seizures SMA lesions [remarks by original authors] [a] + Cerebrum – Neuronal loss + Poorly convoluted Inferior olives Neuronal loss “Typical clusters” Dentate nucleus: A/H + + 140 + + + 27 + 39 M 1 + + + 360 + + + + + 38 37 M 1 (14)(x)(x) Ventral pons atrophy/ hypoplasia + 150 + + + + + 36 F 3 (40)(x) ++ + 180 + + + + <p3 + 38 M 2 (35)(x) DiVuse cerebellar A/H, vermis A/H Neocerebellar atrophy/ + hypoplasia (A/H) Brain weight (g) Neuropathology + + + + <p3 + 37 F 1 (60) + + + + + 29 + 36 F 1 (1)(x) 9 days 10 days 1 day 9 days 1 day 1 day 3 months 12 months 18 days 3,5 months 5 months 6 days ** 4 days 14 days 7 weeks 7 weeks 5 days 3 days 1 day 1 day + + + 33 + 39 M 1 (64)(x) Age at death 32 F 2 (50) Dysmorphic features Hypertonia; Startle reXex Seizures: multiple, severe + 32 Neurological signs/ symptoms + OFC at birth (cm) 37 F 1 (47)(x) Polyhydramnios Term of pregnancy (weeks) 38 1 Patient number Clinical data (37) Reference number Table 3 Patients reported with congenital Olivo-Ponto-Cerebellar atrophy: “severe neonatal type” Acta Neuropathol (2007) 114:387–399 391 123 392 Acta Neuropathol (2007) 114:387–399 Neuropathology Wndings tip of the globus pallidus was approximately 10 mm, compared to 12 mm in a normal control. The transverse diameter of the fully developed thalamus was approximately 5 mm instead of 7 mm in a control. The size of the amygdala was not signiWcantly reduced. Arteries of the circle of Willis had a normal conWguration. Macroscopic examination Microscopic examination The neocerebellar hemispheres were very small, the vermis and Xocculonodular lobes more moderately reduced in size (Figs. 1, 3a). In the midbrain, the cerebral peduncles were small. The ventral aspect of the pons was Xattened (Fig. 1). The diameter of each bulbar pyramid was approximately of 1 mm, compared to 2 mm in a normal control. The spinal cord was thin. The post-Wxation brain weights in patients 2 and 3, both born at term, were 74 and 78 g, respectively (normal: 350– 450 g). In either patient, Wndings were remarkably consistent. The meninges were thickened. Cortical convolutions were small and simpliWed but their general pattern was retained with recognizable primary, secondary and tertiary Wssures. Sulci were enlarged. There was incomplete opercularisation of the lower part of the sylvian Wssure. At the level of the insula, only a very thin band of tissue could be distinguished on the external surface of the putamen (Fig. 2b). The volume of the central and intra-axial white matter was much reduced. The internal capsule was thin. The corpus callosum, on a frontal plane through the anterior nucleus of the thalamus (Fig. 2b), was approximately 1 mm thick (normal control = 2 mm). The fornix, optic tracts and olfactory tracts were identiWed. Lateral ventricles were enlarged. The periventricular germinal matrix was thick for age (Fig. 2a, b). In contrast to the important volumetric reduction of the cerebral cortex and white matter (pallium), the size of the striatum and globus pallidus (Fig. 2b) did not diVer signiWcantly from normal: the distance between the external surface of the putamen and the The very small neocerebellar hemispheres had a smooth surface with only few shallow undulations (Fig. 3a). There were various degrees of cortical alteration. In some areas, the laminar organization was recognizable but Purkinjé cells were absent except for an occasional, isolated, calbindin and MAP-2 positive cell. The thin external granular layer had a normal structure. The internal granular layer was very sparsely populated (Fig. 3b). The shallow molecular layer contained apparently normal GFAP labeled radial glial Wbers (Fig. 3c). Large reactive astrocytes were present. In other areas, the molecular layer had vanished completely to the eVect that remnants of the external and internal granular layers were contiguous. Finally, in the most atrophic regions (Fig. 3d), only a few granular cells remained within a dense glial network. Macrophages were present. The dentate nucleus was small, fragmented and reduced to a few irregular clusters of normal appearing neurons. There was no gliosis. There were no signiWcant microscopic changes in the vermis and Xocculonodular lobes (Fig. 3e). In the atrophic neocerebellar white matter, a dense reactive gliosis was present; no axons were immunostained with neuroWbrillary protein. In this regard, the vermis and Xocculonodular lobes were normal (Fig. 3f). There were no ectopic Purkinjé cells. In the midbrain, the cranial nerve nuclei, nucleus ruber and substantia nigra had a normal structure. The cerebral peduncles were present. In the underdeveloped ventral part of the pons, the number of neurons in the pontine-nuclei were considerably reduced; only very few small aggregates Fig. 1 Neuroimaging. a Neurologically normal neonate. T2-weighted MRI; axial plane at sella turcica showing normal anatomy of pons and cerebellum.b Patient 3. T1-weighted axial MRI at level of hypophysis, showing atrophy of basis pontis (arrowhead) and of cerebellar hemispheres (arrow); T2-weighted images not available. c Normal neonatal brain (same subject as in a). T2-weighted axial section of cerebral hemispheres and basal ganglia at striatal plane. Insular cortex and subjacent white matter (arrow) with thin claustrum therein clearly visible. d Patient 3. T1-weighted axial plane at level of striatum. Severe atrophy of cerebral cortex and white matter. Insular structures not covering the mass of basal ganglia (arrowhead). Considerably enlarged peripheral CSF spaces All sections were examined under the Eclipse E800 Nikon light microscope. Some were selected for photographic recording. 123 Acta Neuropathol (2007) 114:387–399 393 Fig. 2 Cerebrum (patient 3). a Ten-days-old newborn. Normal brain (420 g at term). Frontal section (level slightly anterior to that in b). Note insular cortex (arrowhead), claustrum (arrow). b Patient 3 (at term brain weight 78 g). Frontal section of cerebral hemispheres at the level of anterior thalamic nuclei, amygdala, optic tracts. Atrophy of central and intra-axial white matter. Large cortical sulci and sylvian Wssure. Insular cortex (arrows) very thin and unconvoluted dorsally, absent ventrally. No claustrum. Near normal size of striatum and globus pallidus and amygdala (see text). Thick periventricular germinal matrix. c Higher magniWcation of b. Insular cortex (arrow) thin, unconvoluted in dorsal segment, practically devoid of neurons ventrally. No claustrum. Very thin white matter band (arrowhead) between cortex and putamen (white arrowhead). d Higher magniWcation of c. Neuronal depopulation and marginal gliosis of insular cortex (arrow). No claustrum in white matter band (arrowhead) separating cortex from putamen. e Heterotopic streaks of neurons in central white matter (arrow). Dense gliosis of white matter. (a) cresyl violet-luxol. (b–e) cresyl violet stain of these cells remained (Fig. 4a). There were no ectopic pontine neurons. The remaining ponto-cerebellar axons were thin and fragmented (Fig. 4b). The transversally sectioned bundles of the pyramidal tract were small and so were the middle cerebellar peduncles. The VIth, VIIth and vestibular nuclei were normal. In the medulla, the inferior olives were reduced to a few isolated clumps of normal appearing neurons (Fig. 4c). There was no indication of neuronal degeneration or gliosis, and the nuclei of the other cranial nerves showed no abnormality. No microscopic changes were detected in the pyramids. Only a few neurons remained in the arcuate nuclei, and the site of severe gliosis (Fig. 4c). In the thin spinal cord, the anterior horn cells and other gray structures were normal (Fig. 4d), and the main Wber tracts could be readily discerned. 123 394 Acta Neuropathol (2007) 114:387–399 Fig. 3 Cerebellum (patient 2). a Horizontal section through the cerebellum and upper medulla. Marked reduction in size of neo-cerebellum with very thin cortical band (arrows). Relative preservation of vermian and Xocculonodular structures. b Neocerebellar cortex, mildly aVected segment. Normal structure of the external granular layer. Shallow molecular layer (arrow). No Purkinjé cells. Sparsely populated internal granular layer (arrowhead). c Neocerebellar cortex, moderately aVected segment. Radial glial Wbers (Bergmann glia) are seen crossing the molecular layer to reach the external granular layer. Internal granule cells somewhat sparse. No Purkinjé cell evident. d Neocerebellar cortex, severely aVected segment. Very thin, partially destroyed external granular layer (arrow). No molecular layer. Reactive astrocytes in depopulated internal granular layer. e Vermis. Normal cytoarchitecture of cortex. f Cerebral white matter. Immunostaining of nerve Wbers (axons) in archicerebellum (white arrow), not in atrophic neocerebellar white matter (arrowhead). (a, b, d, e) cresyl violet stain; (c) GFAP, cresyl violet; (f) NeuroWlament protein (NFP) In all parts of the cerebral neocortex, the most superWcial layers (second and third layer) were composed of irregular clumps or bands of adjacent, at times coalescent neurons; no radial arrangement was discernable at this level (Fig. 5a, b). Reactive astrocytes were present. In the lower neocortical segment (layers IV–VI), the cyto-architecture showed no signiWcant change. In the molecular layer, numerous Cajal-Retzius cells labeled with reelin and MAP2, were observed (Fig. 5b). There was no trace of a subpial granular layer. The cortex of the superior temporal gyri was irregularly undulated. Thin bands or islands of neurons appeared occasionally in the molecular layer, possibly as a result of a section artefact (Fig. 5c). The most striking cortical abnormalities were seen in the region of the insula (Fig. 2b–d). In its upper third, the insular cortex was very thin and unconvoluted. In its lower part, nearly all neurons were either absent or grouped in minute islets; reactive astrocytes were present. There was no claustrum and consequently, the insula and putamen were separated only by a narrow band of white matter (Fig 2c, d). The hippocampus was normal except for a limited loss of pyramidal cells in Sommer’s sector in patient 3. The amygdala had a normal structure. The striatum and globus pallidus (Fig. 2b) showed no microscopic alteration. There was no signiWcant cell loss in the thalamus. In the atrophic central and intra-axial white matter, dense gliosis and streaks of elongated heterotopic neurons were observed (Fig. 2e). No myelinated Wbers were 123 Acta Neuropathol (2007) 114:387–399 395 Fig. 4 Brain stem (patient 2). a Pons—Basis Pontis. Near absence of pontine nuclei neurons. A few remain (arrow). DiVuse gliosis. b Basis pontis. Rare pontocerebellar axons, thin and fragmented (arrows). c Medulla. Inferior olives are reduced to small unconvoluted masses of neurons (arrows). Pyramidal tracts (white arrowhead). Gliosis in arcuate nuclei (black arrowhead). d Upper spinal cord—Anterior horn cells are present (arrow). (a, c, d), cresyl violet stain; (b) Bodian stain Fig. 5 Neocortex. (patient 3). a Frontal cortex. Disorganized cytoarchitectonics of superWcial cortical layers. Irregular aggregates of dark, partly coalescent neurons. b Immunostaining of neurons and dendrites in frontal cortex. Compare to a. Note Cajal-Retzius cells (arrow). c Temporal cortex. Irregular undulations of upper layers (arrow). Bands or round aggregates of neurons in molecular layer (arrowhead). (a, c) cresyl violet stain. (b) MAP-2 stain detected. A thin internal capsule was identiWed. The corpus callosum and the optic tracts had a normal microscopic structure. The periventricular matrix was thick for age (compare Fig. 2a, b). The ependymal lining of the cerebral ventricles was normal. Discussion As their molecular basis is still unknown, diVerent forms of idiopathic congenital olivopontocerebellar atrophy/hypoplasia are classiWed according to clinical and neuropathologic 123 396 criteria. Two among them have been delineated by Barth [4]. In PCH type 2, the most coherent group [3, 5, 9, 11–13, 27, 30, 31, 49, 52, 54, 56, 59] and Table 2, initially described by Brun [11], a major and practically constant feature is dystonia. Motor and mental development is very limited, and head circumference is reduced. Most children die in late infancy or early childhood; a few live longer. Survival beyond the third year of life has been reported in some patients in whom no post-mortem examination had been performed [2, 5, 17]. In PCH type-1 patients [16, 21, 22–28, 29, 36, 42–45, 53, 63] and Table 1, degeneration of the spinal and brain stem motor neurons and of some thalamic neurons is associated with the typical olivopontocerebellar defects. Clinical evidence of SMA is usually but not consistently present. In some of these subjects with obvious developmental delay, brain weight is normal for age or only moderately reduced. The initial patient with this type of PCH was described by Norman [43] and a second one by Norman and Kay [45]. Involvement of the SMN1 gene locus on 5q11.2-q13.3 has been excluded in two families with PCH type 1 [22, 53]. We concur with Barth [6] who stated that some patients with idiopathic congenital PCH were diYcult to classify. The clinical features in our patients–intractable seizures, excessive startle response, central hypoventilation, polyhydramnios, marked reduction of brain volume and neonatal death–diVer from the ones in PCH1 and in PCH2, but are comparable to a number of patients previously reported under various denominations [1, 14, 20, 35, 37, 40, 47, 48, 50, 60, 64] listed in Table 3. Some of the latter have recently been labeled PCH4 by Patel et al. [48] who also used PCH5 to designate the clinical and neuropathological characteristics in three sibs with prenatal seizures and marked vermian predominance of cerebellar lesions. The term PCH3 had been used previously as well to name the condition reported in three siblings, two of whom had MRI Wndings of diVuse atrophy of the central nervous system at 12 and 6 years of age, respectively, and one a large cisterna magna and an atrophic cerebellum [46, 51]. Linkage to chromosome 7q11-21 was found [51]. A generalized atrophy of the central nervous system also characterized the patients reported by Zelnik et al. [66]. Because of the considerable volumetric reduction of the entire central nervous system revealed by the available MRI documents and the lack of any neuropathology study, the basic morphologic criteria necessary for the delineation of a new type of congenital PCH were not fulWlled in these patients. In order to avoid further confusion of terminology, we propose to refer to the fairly coherent assembly of patients listed in Table 3 as to the “severe neonatal type” of congenital non-syndromic PCH, especially at present with the apparently monogenic cause(s) still unidentiWed. 123 Acta Neuropathol (2007) 114:387–399 While displaying the characteristic brain stem and cerebellar changes common to all types of PCH as well as the clinical features of the “severe neonatal form” (Table 3), our patients present in addition extreme micrencephaly and unique developmental abnormalities in the cerebral cortex that clearly sets them apart. A small brain is, with few exceptions, featured in all types of PCH. However, in our patients the reduction of brain size at term (74 and 78 g compared to the normal of at least 350 g), was far more pronounced than in PCH1 and PCH2 (Tables 1, 2) and even more extreme than in the patients grouped here into the “severe neonatal category”. The micrencephaly was essentially the consequence of the volumetric reduction of the neo-cortex and hemispheric white matter (Pallium), whereas the size of the Striatum and Globus pallidus was practically normal (Fig. 2) and that of the thalamus only moderately reduced. In striking contrast, the reduction of head size was only mild. This discrepancy remains unexplained, but supports the contention that in neonates and young infants, reduction of occitipofrontal circumference is not always directly correlated with reduction of brain volume. Small brains weighing at term less than 100 g and called “microbrains” [24] occur in other conditions. They have been associated with various types of cortical dysplasia in congenital malformation syndromes such as the Neu-Laxova syndrome and in cases of autosomal recessive lissencephaly with cerebellar defects. Microbrains have also been observed in infants with a normal cortical pattern [24, 38]. In addition to the considerable volumetric reduction, the cerebrum of our patients showed unique neocortical and subcortical (pallial) abnormalities: absence of the claustrum, neuronal depletion in the insula, and cytoarchitectonic changes of the superWcial, late migrating, layers in the other regions of the neocortex (Figs. 2, 5). This constellation of cerebral anomalies is not reported in any type of PCH, where only minor and unspeciWc changes have occasionally been observed (Tables 1, 2). It supports the contention that our patients represent a hitherto unrecognized severe variant of PCH. Absence of the claustrum, a subcortical structure with connections to many cortical areas [26] is rare in congenital cerebral malformations. It is, however, in our experience also a feature of lissencephaly type 1. It has been observed as well in a patient with congenital microcephaly of unknown causation, in association with widespread degeneration of late migrating neurons, particularly in the insula and without signiWcant cerebellar and brainstem anomalies (Miller 2002 personal communication). In an attempt to shed some light on the pathogenesis of the apparently autosomal recessive developmental disorder presented, we have adhered to two lines of thought. First, we have compared the pattern of brain stem and cerebellar Acta Neuropathol (2007) 114:387–399 abnormalities in our patients with the ones in previously reported patients with PCH in order to sort potentially primary from secondary eVects of the mutant gene(s) upon the cerebellar circuitry [57]. Second, we have carefully weighted our patients’ cerebellar and cerebral defects against the CNS anomalies in mutant mice with both hindbrain and forebrain anomalies on the one hand, and against some other human cerebral developmental anomalies on the other. In our patients, the number of ponto-cerebellar neurons (neurons in pontine nuclei) were considerably reduced, and the neo-cerebellar granule cell layer to which these neurons project was depopulated. As a similar reduction of the number of pontine nuclei is found also in cases of PCH in which neo-cerebellar granule cells are apparently not aVected, a primary eVect of the causal mutation upon ponto-cerebellar neurons is probable. It is of note that the neurons in the pontine nuclei remain intact in the so-called “primary degeneration of the granule cell layer” [43] an apparently autosomal recessive condition in humans. In mice lacking the Math1 gene [7, 62], the ponto-cerebellar neurons (mossy Wbers) are defective, as in PCH, but the cerebellar external granular layer is lacking, which is not the case here. In the “atrophic” neocerebellum in our patients the least aVected segments maintained a recognizable cortical lamination, but Purkinjé cells were extremely rare and the internal granular layer was very sparsely populated. To the contrary, the relatively thin external granular layer retained its normal histologic structure (Fig. 3b), tangential migration of granule cells apparently having been preserved. Radial glial Wbers were present in the shallow molecular layer (Fig. 3c). Similar Wndings were recorded in all types of congenital PCH [4, 11, 14, 29, 35, 37, 47, 50, 63]. The few residual Purkinjé cells were Calbindin positive and MAP2 positive suggesting that these cells degenerated following normal diVerentiation and migration. A similar interpretation has been oVered previously [47]. It can therefore be assumed that the loss of Purkinjé cells probably represents another primary eVect of the mutant gene and the depopulation of the internal granule cells a secondary phenomenon, as Purkinjé cells to which they project and pontine nuclei from which they receive aVerent Wbers, are both deWcient. The normal appearing external granular layer in some areas of the neocerebellum and in the vermis and the presence of “GFAP labeled” glial Wbers in the cerebellar molecular layer (Fig. 3c), are also in favor of this hypothesis. The dentate nucleus was small, fragmented and reduced to irregular clusters of normal appearing neurons. This characteristic pattern and other less frequent alterations are observed in PCH irrespective of the presence or severe reduction in number of neocerebellar Purkinjé cells. Hence, it can hardly be ascribed to an arrest in the fetal develop- 397 ment of this nucleus [32], as had been postulated by Brun [11]. The inferior olives were reduced to a few isolated clumps of normal appearing neurons (Fig. 4c). This typical change as well as other histopathologic alterations observed in PCH–ranging from neuronal loss in a normally convoluted nucleus to marked disruption of its usual pattern—are diYcult to interpret. Although these facts may represent a primary, albeit variable developmental dysplasia, they could alternatively be the consequence of early neuronal degeneration of an initially normal nucleus, as appears to be the case in the “Staggerer” mutant mouse [65]. A striking polymorphism of olivary morphology is also found in other developmental disorders such as dentate-olivary dysplasia [34]. While concluding this section, we postulate that degeneration of Purkinjé cells, ponto-cerebellar neurons and possibly dentate nucleus cells are direct consequences of the gene mutation, although we are fully aware that either mechanism or sequence of the multiple developmental anomalies cannot be ascertained conclusively by any type of post-mortem study of the human CNS. Designation of a candidate mutant gene as the cause of any type of congenital PCH depends either on human linkage data or on the study of mutant genes in the mouse with similar neurodevelopmental defects [15, 61]. Present genetic studies in humans have not yet characterized any signiWcant linkage to a chromosomal site or any potentially causal gene in congenital PCH. Linkage to chromosome 7 was found only in a generalized developmental CNS anomaly in siblings in whom morphologic criteria of congenital PCH have not been formally documented [51]. In reviewing the morphologic defects in several strains of mutant mice with both cerebellar and cerebral malformations, we found that developmental anomalies in the Pax6sey/Pax6sey mutant mouse [23, 58] including absence of the claustrum, dysgenesis of the insular cortex, defective migration of neocortical neurons, poor foliation and cytocortical anomalies in the cerebellum, and disruption of ponto-cerebellar neurons, were strikingly similar to the ones found in our patients, absence of eye changes notwithstanding. However, our cytoimmunochemical studies using a Pax6 antibody showed in the cerebellum and cerebral cortex of our patients and in controls, similar staining intensity and pattern prompting the conclusion of similar Pax6 gene expression in both. The reeler mouse [33] and other recently described mutant mice also display developmental defects in both the rhombencephalon and the cerebral cortex. This is the case of the dreher mutant mouse (drJ) due to a mutation in the Lmx1a gene [18, 25, 39], and of the developmental defect produced by a mutation in the Lhx2 gene [8, 41]. The pallial changes in murine mutants of the homeobox transcription 123 398 factors Emx1 and Emx2 [10, 55] diVer from the ones observed in our patients. Moreover, in the latter type of mutant mice, cerebellar defects are lacking. As the phenotypic expression diVers markedly from the dysgenesis of cerebral cortex and cerebellum documented here, the candidate genes cited are unlikely orthologs of the gene causing the type of congenital PCH at hand. However, careful comparison of the neuropathological consequences in either newly discovered or genetically engineered murine mutants with the CNS Wndings in patients with congenital PCH will continue to be helpful in sorting primary from secondary roles of speciWc cell lineages in cerebellar development. Congenital PCH is probably not as rare an autosomal recessive defect in humans as assumed from the literature data, because familial occurrences are largely overrepresented particularly among the patient reports dating from the era preceding eVective neuro-imaging (Tables 1, 2, 3). More reports even of isolated cases with congenital PCH are much needed provided they include complete neuropathology documentation. Possible complacency in the neonatal intensive care units by mere reliance on ultrasonography-based diagnosis in early succumbing infants may be a challenge to the goal of elucidating the monogenic causes of abnormal cerebellar development. Hopefully, this report on only one of several types of PCH may expedite successful molecular steps in the investigations for achieving that goal. Acknowledgements The authors thank the family for the permission granted to study the patients and for their persevering conWdence in them. They express gratitude to Dr. H. Zoghbi, Department of Molecular and Human Genetics, to Dr. D. Armstrong, Department of Neuropathology, Baylor College of Medicine, Houston, Texas, to Dr. JJ Hauw and Dr. Ch. Duyckaerts, Department of Neuropathology, Hôpital de la Salpétrière, Paris, to Dr. M. Wassef, Directeur de Recherche CNRS, Paris, France and to Dr. Ph. Evrard, Department of Pediatric Neurology, Hôpital R. Debré, Paris and Dr. C. Verney, Inserm U 676, Hôpital R. Debré, for valuable advice and/or critical review of the manuscript. Thanks go to Dr. V. Meersschaut and to Mrs. M-L. Duyts, Department of Radiology, Ghent University Hospital, for the comparative neuroimaging and excellent photographic recording respectively. The authors owe much gratitude to Mr. L. Draon, Department of Child Neurology, Hôpital R. Debré, Paris, for expert photographic and digital production skills applied to all illustrations. Also, the dedication and careful secretarial assistance of Mrs. A. Gailly, Paris and of Mrs. K. Buchanan, Greenwood Genetic Center (GGC), Greenwood, South Carolina, deserve authors’ sincere acknowledgement. JGL expresses gratitude for the hospitality oVered by the Department of Molecular and Human Genetics, Houston, Texas and by the GGC during his recurrent episodes as a visiting scholar. References 1. Albrecht S, Schneider MC, Belmont J, Armstrong DL (1993) Fatal infantile encephalopathy with olivopontocerebellar hypoplasia and micrencephaly. Report of three siblings. Acta Neuropathol (Berl) 85:394–399 123 Acta Neuropathol (2007) 114:387–399 2. Barbot C, Carneiro G, Melo J (1997) Pontocerebellar hypoplasia with microcephaly and dyskinesia: report of two cases. Dev Med Child Neurol 39:554–557 3. Barth PG, Vrensen GFJM, Uylings HBM, Oorthuys JW, Stam FC (1990) Inherited syndrome of microcephaly, dyskinesia and pontocerebellar hypoplasia: a systemic atrophy with early onset. J Neuro Sci 97:25–42 4. Barth PG (1993) Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset. Brain Dev 15:411–422 5. Barth PG, Blennow G, Lenard H-G, Begeer JH, van der Kley JM, Hanefeld F, Peters AC, Valk J (1995) The syndrome of autosomal recessive pontocerebellar hypoplasia, microcephaly and extrapyramidal dyskinesia (pontocerebellar hypoplasia type 2): compiled data from ten pedigrees. Neurology 45:311–317 6. Barth PG (2000) Pontocerebellar hypoplasia- how many types? Eur J Paediatr Neurol 4:161–162 7. Ben-Arie N, Bellen HJ, Armstrong DL, McCall AE, Gordadze PR, Guo Q, Matzuk MM, Zoghbi HY (1997) Math 1 is essential for genesis of cerebellar granule neurons. Nature 390:169–172 8. Bertuzzi S, Porter FD, Pitts A, Kumar M, Agulnik A, Wassif C, Westphal H (1999) Characterization of Lhx9, a novel LIM/homeobox gene expressed by the pioneer neurons in the mouse cerebral cortex. Mech Dev 81:193–198 9. Biemond A (1955) Hypoplasia ponto-neocerebellaris with malformation of the dentate nucleus. Folia Psychiatr Neurol Neurochir Ned 58:2–7 10. Bishop KM, Rubinstein GL, O’Leary DD (2002) Distinct actions of Emx 1, Emx 2, and Pax 6 in regulating speciWcation of areas in the developing neocortex. J Neurosci 22:7627–7638 11. Brun R (1917) Zur Kenntnis der Bildungsfehler des Kleinhirns. Schweiz Arch Neurol Psychiatr 1:61–123 12. Brun R (1918a) Zur Kenntnis der Bildungsfehler des Kleinhirns. Schweiz Arch Neurol Psychiatr 2:48–105 13. Brun R (1918b) Zur Kenntnis der Bildungsfehler des Kleinhirns. Schweiz Arch Neurol Psychiatr 3:13–88 14. Chavez-Vischer V, Pizzolato GP, Hanquinet S, Maret A, Bottani A, Haenggeli CA (2000) Early fatal pontocerebellar hypoplasia in premature twin sisters. Eur J Paediatr Neurol 4:171–176 15. Chizhikov V, Millen KJ (2003) Development and malformations of the cerebellum in mice. Mol Genet Metab 80:54–65 16. Chou SM, Gilbert EF, Chun RW, Laxova R, TuZi GA, SuWt RL, Krassinot N (1990) Infantile olivopontocerebellar atrophy with spinal muscular atrophy (infantile OPCA+ SMA). Clin Neuropathol 9:21–31 17. Coppola G, Muras I, Pascotto A (2000) Pontocerebellar hypoplasia 2 (PCH2): report of two siblings. Brain Dev 22:188–192 18. Costa C, Harding B, Copp AJ (2001) Neuronal migration defects in the dreher (Mlx1a) mutant mouse: role of disorders of the glial limiting membrane. Cereb Cortex 6:498–505 19. De Bergeyck V, Naerhayzen B, GoVinet AM, Lambert de Rouvroit C (1998) A panel of monoclonal antibodies against Reelin, the extracellular matrix protein defective in Reeler mutant mice. J Neurosci Methods 82:17–24 20. De Koning TJ, De Vries LS, Groenendaal F, Ruitenbeek W, Jansen GH, Poll-Thé BT, Barth PG (1999) Pontocerebellar hypoplasia associated with respiratory-chain defects. Neuropediatrics 30:93–95 21. De Leon GA, Grover WD, D’Cruz CA (1984) Amyotrophic cerebellar hypoplasia. A speciWc form of infantile spinal atrophy. Acta Neuropathol (Berl) 63:282–286 22. Dubowitz V, Daniels RJ, Davies KE (1995) Olivopontocerebellar hypoplasia with anterior horn cell involvement (SMA) does not localize to chromosome 5q. Neuromuscul Disord 5:25–29 23. Engelkamp D, Rashbass P, Seawright A, Van Heyningen V (1999) Role of Pax 6 in development of the cerebellar system. Development 126:3585–3596 Acta Neuropathol (2007) 114:387–399 24. Evrard Ph, Lyon G, Gadisseux JF (1984) Le développement prénatal du système nerveux et ses perturbations. Progrès Neonatol 4:71–85 25. Failli V, Bachy I, Retaux S (2002) Expression of the LIM-homeodomain gene Lmx1a (dreher) during development of the mouse nervous system. Mech Dev 118:225–228 26. FilimonoV IN (1966) The claustrum, its origin and development. J Hirnforsch 8:503–528 27. Gadisseux JF, Rodriguez J, Lyon G (1984) Pontocerebellar hypoplasia. A probable consequence of prenatal destruction of the pontine nuclei and a possible role of phenytoin intoxication. Clin Neuropathol 3:160–167 28. Görgen-Pauli U, Sperner J, Reiss I, Gehl HB, Reusche E (1999) Familial pontocerebellar hypoplasia type 1 with anterior horn cell disease. Eur J Paediatr Neurol 3:33–38 29. Goutières F, Aicardi J, Farkas E (1977) Anterior horn cell disease associated with pontocerebellar hypoplasia in infants. J Neurol Neurosurg Psychiatr 40:370–378 30. Grellner W, Rohde K, Wilske J (2000) Fatal outcome in a case of pontocerebellar hypoplasia type 2. Forensic Sci Int 113:165–172 31. Gross H, Kaltenbäck E (1959) Über eine kombinierte progressive pontocerebellare systematrophie bei einem kleinkind. Dtsch Z Nervenheilkd 179:388–400 32. Gudovi R, Marinkovi R, Aleksi S (1987) The development of the dentate nucleus in man. Anat Anz Iena 163:233–238 33. Hamburgh M (1963) Analysis of the postnatal developmental eVects of « Reeler », a neurological mutation in mice. A study in developmental genetics. Dev Biol 19:165–185 34. Harding BN, Boyd SG (1991) Intractable seizures from infancy can be associated with dentate-olivary dysplasia. J Neurol Sci 104:157–165 35. Hashimoto K, Takeuchi Y, Kida Y, Hasegawa H, Kantake M, Sasaki A, Asanuma K, Isumi H, Takashima S (1998) Three siblings of fatal infantile encephalopathy with olivopontocerebellar hypoplasia and microcephaly. Brain Dev 20:169–174 36. Kamoshita S, Takei Y, Miyao M, Yanagisawa M, Kobayashi S, Saito K (1990) Pontocerebellar hypoplasia associated with infantile motor neuron disease (Norman’s disease). Pediatr Pathol 10:133–142 37. Kawagoe T, Jacob H (1986) Neocerebellar hypoplasia with systemic combined olivopontodentatal degeneration in a 9-day-old baby: contribution to the problem of relations between malformation and systemic degeneration in early life. Clin Neuropathol 5:203–208 38. Lyon G (1995) Congenital malformation of the brain. In: Levene MI, Lilford RJ (eds) Fetal and neonatal neurology and surgery, 2nd edn. Churchill Livingstone, London, pp 193–214 39. Millonig JH, Millen KJ, Hatten ME (2000) The mouse Dreher gene Lmx1a controls formation of the roof plate in the vertebrate CNS. Nature 403:764–769 40. Mitra AG, Salvino AR, Spence JE (1999) Prenatal diagnosis of fatal infantile olivopontocerebellar hypoplasia syndrome. Prenat Diagn 19:375–378 41. Monuki ES, Porter FD, Walsch CA (2001) Patterning of the dorsal telencephalon and cerebral cortex by a roof plate-Lhx2 pathway. Neuron 32:591–604 42. Muntoni F, Goodwin F, Sewry C, Cox P, Cowan F, Airaksinen E, Patel S, Ignatius J, Dubowitz V (1999) Clinical spectrum and diagnostic diYculties of infantile pontocerebellar hypoplasia type 1. Neuropediatrics 30:243–248 43. Norman RM (1940) Primary degeneration of the granular layer of the cerebellum: an unusual form of familial cerebellar atrophy occurring in early life. Brain 63:365–379 44. Norman RM (1961) Cerebellar hypoplasia in Werdnig-HoVmann disease. Arch Dis Child 36:96–101 45. Norman RM, Kay JM (1965) Cerebello-thalamo-spinal degeneration in infancy: an unusual variant of Werdnig-HoVmann disease. Arch Dis Child 40:370–378 399 46. Parisi MA, Dobyns WB (2003) Human malformations of the midbrain and hindbrain: review and proposed classiWcation scheme. Mol Genet Metab 80:36–53 47. Park SH, Becker-Catania S, Gatti RA, Crandall BF, Emelin JK, Vinters HV (1998) Congenital olivopontocerebellar atrophy: report of two siblings with paleo- and neocerebellar atrophy. Acta Neuropathol (Berl) 96:315–321 48. Patel MS, Becker LE, Toi A, Armstrong DL, Chitayat D (2006) Severe, fetal-onset form of olivopontocereballar hypoplasia in three sibs: PCH Type 5? Am J Med Genet 140A:594–603 49. PeiVer J, PfeiVer RA (1977) Hypoplasia pontocerebellaris. J Neurol 215:241–251 50. Pittella JE, Nogueira AM (1990) Pontocerebellar hypoplasia: report of a case in a newborn and review of the literature. Clin Neuropathol 9:33–38 51. Rajab A, Mochida GH, Hill A, Ganesch V, Bodell A, Riaz A, Grant PE, Shugart YY, Walsh CA (2003) A novel form of pontocerebellar hypoplasia maps to chromosome 7q11-21. Neurol 60:1664–1667 52. Robain O, Dulac O, Lejeune J (1987) Cerebellar hemispheric agenesis. Acta Neuropathol (Berl) 74:202–206 53. Rudnik-Schöneborn S, Wirth B, Röhrig D, Saule H, Zerres K (1995) Exclusion of the gene locus for spinal muscular atrophy on chromosome 5q in a family with infantile olivopontocerebellar atrophy (OPCA) and anterior horn cell degeneration. Neuromuscul Disord 5:19–23 54. Scherer HJ (1933) Beiträge zur pathologischen Anatomie des Kleinhirns. III. Genuine Kleinhirnatrophien. Ztschr Ges Neurol Psychiatr Orig 145:335–349 55. Shinozaki K, Yoshida M, Nakamura M, Aizawa S, Suda Y (2004) Emx 1 and Emx 2 cooperate in initial phase of archipallium development. Mech Dev 121:475–489 56. Simonati A, Dalla Bernardina B, Colombari R, Rizzuto N (1997) Pontocerebellar hypoplasia with dystonia: clinicopathological Wndings in a sporadic case. Childs Nerv Syst 13:642–647 57. Sotelo C, Mariani J (1999) Research strategies for the analysis of neurological mutants in mice. In: Crassio WE, Gerlai RT (eds) Handbook of molecular genetic techniques for brain and behavior research. Techniques in the behavioral and neural sciences, vol 13. Elsevier Science, Amsterdam, pp 132–146 58. Stoykova A, Treichel D, Hallonet M, Gruss P (2000) Pax 6 modulates the dorsoventral patterning of the mammalian telencephalon. J Neurosci 20:8042–8050 59. Uhl M, Pawlik H, Laubenberger J, Darge K, Baborie A, Korinthenberg R, Langer M (1998) MR Wndings in pontocerebellar hypoplasia. Pediatr Radiol 28:547–555 60. Vossbeck S, Scheuerle A, Bechinger D, Pohlandt F (1997) Olivopontocerebral hypoplasia—case report of a neurodegenerative disease manifesting at birth with fatal outcome. Klin Pädiat 209:137–140 61. Wang VY, Zoghbi HY (2001) Genetic regulation of cerebellar development. Nat Rev Neurosci 2:484–491 62. Wang VY, Rose MF, Zoghbi HY (2005) Math 1 expression redeWnes the rhombic lip derivatives and reveals novel lineages within the brain stem and cerebellum. Neuron 48:31–43 63. Weinberg AG, Kirkpatrick JP (1975) Cerebellar hypoplasia in Werdnig-HoVmann disease. Dev Med Child Neurol 17:511–516 64. Young ID, McKeever PA, Squier MV, Grant J (1992) Lethal olivopontoneocerebellar hypoplasia with dysmorphic features in sibs. J Med Genet 29:733–735 65. Zanjani HS, Herrup K, Guastavino JM, Delaye-Bouchaud N, Mariani J (1994) Development of the inferior olivary nucleus in Staggerer mutant mice. Dev Brain Res 82:18–28 66. Zelnik N, Dobyns WB, Forem SL, Kolodny EH (1996) Congenital pontocerebellar atrophy in three patients: clinical, radiologic, and etiologic considerations. Neuroradiology 38:684–687 123